ANKARA (Bernama): The full two doses of the CoronaVac Covid-19 vaccine, produced by Chinese company Sinovac, produces a strong antibody response in children over three years old and teenagers, Anadolu Agency (AA) quoted a new study Tuesday (June 29).
The Lancet Infectious Diseases journal reported on Phase 1 and Phase 2 trials of CoronaVac run in the north-eastern Chinese province of Hebei in children and adolescents aged three to 17 years old.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!